Kitanotatsujin Corp
TSE:2930
Kitanotatsujin Corp
Cost of Revenue
Kitanotatsujin Corp
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Kitanotatsujin Corp
TSE:2930
|
Cost of Revenue
-¥3.8B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-23%
|
|
Shiseido Co Ltd
TSE:4911
|
Cost of Revenue
-¥321.6B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-5%
|
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Cost of Revenue
-¥113.6B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-7%
|
|
Pola Orbis Holdings Inc
TSE:4927
|
Cost of Revenue
-¥31.2B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
Kao Corp
TSE:4452
|
Cost of Revenue
-¥968.1B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-5%
|
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Cost of Revenue
-¥78.5B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-4%
|
See Also
What is Kitanotatsujin Corp's Cost of Revenue?
Cost of Revenue
-3.8B
JPY
Based on the financial report for Feb 29, 2024, Kitanotatsujin Corp's Cost of Revenue amounts to -3.8B JPY.
What is Kitanotatsujin Corp's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-23%
Over the last year, the Cost of Revenue growth was -52%. The average annual Cost of Revenue growth rates for Kitanotatsujin Corp have been -19% over the past three years , -16% over the past five years , and -23% over the past ten years .